Synergy Research Group Inc

The Duke Clinical Research Institute (DCRI) in Durham, NC is the largest academic research organization globally, specializing in innovative, multi-center clinical research across various diseases, with a particular focus on cardiology. With over 1,300 employees, including more than 200 faculty members from diverse disciplines, the DCRI conducts studies at over 3,500 sites in 64 countries, enrolling more than 1,050,000 patients in their research projects. Known for its extensive publications in peer-reviewed journals and completion of over 730 phase I-IV trials and outcomes research projects, the DCRI has evolved from its origins as the Duke Databank for Cardiovascular Diseases. The institute offers a comprehensive training program for future investigators, providing hands-on experience in domestic and international clinical trials, protocol development, study operations, and more. With a commitment to improving patient care through knowledge development and sharing, the DCRI continues to be at the forefront of clinical research.Generated from the website

Almac Diagnostic Service is a leading provider of precision medicine solutions, offering a wide range of genomic services and diagnostic assays for clinical trials and companion diagnostics. With state-of-the-art laboratories in the UK, US, and Asia, they provide global clinical trial testing and sample management services, along with expertise in data sciences and bioinformatics. Additionally, Almac Diagnostic Service offers consultancy services and a unique gene expression report called claraT. They are part of the Almac Group, a global bioPharma partner known for their advanced platforms and technologies in DNA and RNA sequencing, as well as liquid biopsy solutions. With a strong focus on quality management and a commitment to innovation, Almac Diagnostic Service is at the forefront of biomarker discovery and clinical support in the field of precision medicine.Generated from the website

Bioexel is a global Functional Service Provider (FSP) and Contract Research Organization (CRO) that offers a comprehensive range of clinical trial services to pharmaceutical, medical device, and diagnostic companies. With a team of skilled professionals, Bioexel specializes in therapeutic areas such as oncology, inflammation, cardiovascular diseases, dermatology, endocrinology, ENT, gastroenterology, infectious diseases, medical devices, mental health, and musculoskeletal disorders. Driven by science and technology, Bioexel aims to redefine the clinical trial process and provide quality-driven solutions for all trial phases, from early development to complex late-stage programs. With a focus on insight-driven decision-making and leveraging big data, Bioexel helps life sciences companies navigate the increasingly complex clinical development landscape and meet regulatory, payer, and public expectations for safe and cost-effective trials.Generated from the website